YOLFTbeta
Cantourage Group SE

Cantourage Group SE

HIGH · XETRA · Healthcare / Drug Manufacturers - Specialty & Generic

4.85EUR-0.05 (-1.02%)

Price History

Full chart

Market Stats

Previous Close4.90
Open4.78
Day Range4.66 – 4.89
52-Week Range2.35 – 6.86
Volume3.06K
Market Cap62.76M
P/E (TTM)0.00
Forward P/E19.57
EPS-0.33
Dividend Yield0.00%
Beta-0.07
50-Day Avg5.66
200-Day Avg5.22

About

Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Philip Schetter
  • Employees0
  • HeadquartersFeurigstr. 54, Berlin, Germany, 10827, Germany
  • Websitehttps://www.cantourage.com

Leadership

  • Mr. Philip SchetterCEO & Chairman of Management Board
  • Ms. Monique JaqqamCFO & Member of Exceutive Board
  • Mr. Bernhard RetzerVP Sourcing and Sales & Member of Executive Board
  • Ms. Constanze PelzerVP Quality and Regulatory Affairs & Member of Executive Board
  • Mr. Manuel TaverneHead of Investor Relations

Financials

Income Statement

Currency: EUR2020-12-312021-12-312022-12-312023-12-31
Total Revenue529.64K5.22M603.31K23.56M
Growth (%)-+884.76%-88.43%+3804.60%
Cost of Revenue428.57K3.38M-16.15M
Gross Profit101.08K1.83M-7.41M
Gross Margin19.08%35.15%-31.45%
Operating Expense687.65K2.79M-11.74M
Operating Income-586.57K-953.60K28.73K-4.33M
Operating Margin-110.75%-18.28%4.76%-18.37%
EBITDA--809.14K28.73K-248.01K
EBITDA Margin--15.51%4.76%-1.05%
Net Income-587.28K-969.39K9.01K-4.27M
Net Income Margin-110.88%-18.59%1.49%-18.14%
Interest Expense0--17.53K
Interest Expense % of Total Revenue0.00%--0.07%

Balance Sheet

Currency: EUR2020-12-312021-12-312022-12-312023-12-31
Total Assets1.77M4.87M44.78M44.18M
Total Liabilities163.69K1.23M565.89K4.16M
Total Equity1.61M3.64M44.22M39.95M
Cash971.26K1.96M3.38M1.02M

Cash Flow

Currency: EUR2020-12-312021-12-312022-12-312023-12-31
Capital Expenditure0000

Key Statistics & Ratios

Market Cap62.76M
Enterprise Value61.00M
Trailing P/E0.00
Forward P/E19.57
Price / Sales16.06
Price / Book1.47
EPS-0.33
Revenue (TTM)3.91M
Gross Profit (TTM)3.91M
Profit Margin3.24%
Operating Margin4.59%
Return on Equity0.28%
Return on Assets0.25%
Shares Outstanding11.88M
Shares Float0
Beta-0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%